Erika Sloan
Appearances
- DateMay 18, 2024Esophageal adenocarcinoma (EAC) has had a rising incidence in the US, prompting guidelines for endoscopic screening in those with risk factors for its precursor Barret’s esophagus (BE)…
Presenter
Speakers
University of Kansas School of Medicine and Kansas City VA Medical CenterWashington University School of MedicineWashington University in St. LouisUniversity of Colorado School of MedicineUniversity of ColoradoUCLANorthwestern University - DateMay 19, 2024INTRODUCTION: EET is endorsed by guidelines for treatment of BE-related neoplasia patients. Few studies describe long-term durability outcomes in BE patients who achieve complete eradication of intestinal metaplasia (CE-IM) following EET…
Presenter
Speakers
UCLAUniversity of Kansas School of Medicine and Kansas City VA Medical CenterWashington University School of MedicineWashington University in St. LouisUniversity of Colorado School of MedicineNorthwestern UniversityUniversity of Colorado
